The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
US7585861B2
申请人:——
公开号:US7585861B2
公开(公告)日:2009-09-08
[EN] HIV INHIBITING 1,2,4-TRIAZINES<br/>[FR] 1,2,4-TRIAZINES INHIBANT LE VIH
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2004074266A1
公开(公告)日:2004-09-02
The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
本发明涉及公式(I)中定义的HIV复制抑制剂,其用作药物,它们的制备方法以及包含它们的药物组合物。
3-(Arylamino)-1,2,4-triazin-5-one: A Novel Synthesis and Its Use
An optimized procedure is given for the synthesis of novel 3-(arylamino)-1,2,4-triazin-5-one building blocks from commercially available material. By employing these building blocks, a practical protocol is described for the functionalization of the 5-position of the triazine core with anilines orphenols.